VanEck Pharmaceutical ETF
PPH
#1353
ETF rank
$0.92 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
$107.91
Share price
-1.94%
Change (1 day)
26.24%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of July 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of July 2026: 0.36%